The purpose of this study is to assess if a zoledronic acid injection can alter the trajectory of joint degeneration following an acute anterior cruciate ligament (ACL) injury.
Full record on ClinicalTrials.gov (NCT ID NCT05204836).
Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention
University of Calgary · Interventional, Randomized
17 views
★
★
★
★
★
Study context
Single-site study
Overview
Recruitment criteria
Age range: 25–45 · Sex: All · Healthy volunteers: Requires diagnosis
Study design
- Phase
- Phase 1
- Study type
- Interventional
- Allocation
- Randomized
- Masking
- Single-blind
- Intervention model
- Parallel assignment
- Primary purpose
- Treatment
- Enrollment target
- — participants
- Started
- May 2023
Outcome measures
Locationsi
1 site participated during the trial period. Representative sites shown below; full historical record on ClinicalTrials.gov.
University of Calgary — Calgary, Alberta (Canada)
Sources
ClinicalTrials.gov — NCT05204836
Trial registry · primary record